A rating of 95 puts Mereo BioPharma Group plc - ADR (MREO) near the top of the Biotechnology industry according to InvestorsObserver. Mereo BioPharma Group plc - ADR's score of 95 means it scores higher than 95% of stocks in the industry. Mereo BioPharma Group plc - ADR also received an overall rating of 82, putting it above 82% of all stocks. Biotechnology is ranked 28 out of the 148 industries.
MREO has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on MREO!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 82 means the stock is more attractive than 82 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Mereo BioPharma Group plc - ADR Stock Today?
Mereo BioPharma Group plc - ADR (MREO) stock is trading at $1.38 as of 1:41 PM on Friday, Aug 12, a gain of $0.23, or 20% from the previous closing price of $1.15. The stock has traded between $1.20 and $1.44 so far today. Volume today is high. So far 2,758,209 shares have traded compared to average volume of 2,022,675 shares.
Click Here to get the full Stock Report for Mereo BioPharma Group plc - ADR stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
